Note 6. Revenue

 

The following table disaggregates net revenues by categories (in thousands):

 

  

Year Ended December 31, 2025

 
  

e-Commerce Operations

  

Healthcare Operations

  

Total

 

e-Commerce revenue

 $14,608  $  $14,608 

Pharmacy prescription and other revenue, net of PBM fees

     35,704   35,704 

Pharmacy 340B contract revenue

     4,010   4,010 

Revenues, net

 $14,608  $39,714  $54,322 

 

  

Year Ended December 31, 2024

 
  

e-Commerce Operations

  

Healthcare Operations

  

Total

 

e-Commerce revenue

 $13,791  $  $13,791 

Pharmacy prescription and other revenue, net of PBM fees

     41,907   41,907 

Pharmacy 340B contract revenue

     10,384   10,384 

Revenues, net

 $13,791  $52,291  $66,082 

  

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Mar 24, 2025
2023Apr 11, 2024

About Revenue Disclosures

Revenue disclosures under ASC 606 explain how a company identifies performance obligations, allocates transaction prices, and determines when revenue is recognized. This section is essential for understanding whether reported revenue reflects genuine economic activity or aggressive accounting choices. Analysts examine the mix of point-in-time versus over-time recognition, which directly affects revenue timing and comparability.

Key signals: rising contract liabilities (deferred revenue) suggest strong future revenue visibility, while declining contract assets may indicate slowing project milestones. Watch for variable consideration estimates — rebates, returns, and performance bonuses that require management judgment. Significant changes in disaggregated revenue by geography or product line can reveal shifting business mix before it appears in headline numbers. Compare revenue growth against contract liability growth to assess sustainability, and scrutinize any changes in the timing of recognition that coincide with earnings pressure.